Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H35NO15 |
Molecular Weight | 529.4896 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 14 / 14 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]2(O[C@@H](C=O)[C@@H](O[C@@]1([H])O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H](O)[C@H](O)CO)O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O
InChI
InChIKey=FLZWAAFMRTZQGV-ULZIYQADSA-N
InChI=1S/C20H35NO15/c1-6-12(27)16(31)17(32)20(33-6)35-10(5-24)18(13(28)8(26)3-22)36-19-11(21-7(2)25)15(30)14(29)9(4-23)34-19/h5-6,8-20,22-23,26-32H,3-4H2,1-2H3,(H,21,25)/t6-,8+,9+,10-,11+,12+,13-,14-,15+,16+,17-,18+,19+,20-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7249368
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7249368
A-TRISACCHARIDE (or Blood group A trisaccharide), a core antigen fragment in ABO blood group system. It was found to be a major urinary carbohydrate depending on diet and blood type.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Urinary levels of blood group A trisaccharide: observations in two siblings with neuronal ceroid lipofuscinosis. | 1981 Jul 18 |
|
Conformational analysis of blood group A trisaccharide in solution and in the binding site of Dolichos biflorus lectin using transient and transferred nuclear Overhauser enhancement (NOE) and rotating-frame NOE experiments. | 1996 Aug 1 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
18887
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
20287
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
27988
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
18086
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50198042
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
PRIMARY | |||
|
71587158
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
PRIMARY | |||
|
P104QT2V1B
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
PRIMARY | |||
|
35930
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
PRIMARY | |||
|
49777-13-1
Created by
admin on Sat Dec 16 05:44:32 GMT 2023 , Edited by admin on Sat Dec 16 05:44:32 GMT 2023
|
PRIMARY |
ACTIVE MOIETY